Ólanrewaju O. Okusanya

ÓO

Statistics

Publications

Citations

H-Index

Active since

2003

Affiliations

Institute for Clinical Pharmacodynamics (United States)(Current)

University of Oxford

United States Food and Drug Administration

JMI Laboratories

University at Buffalo, State University of New York

Ólanrewaju O. Okusanya is an author at Institute for Clinical Pharmacodynamics (United States) specializing in pharmacology, medicine, and pharmacokinetics of antimicrobials.

ORCID

Publications per year

2003–2022

Publications

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection Model

Brian VanScoy, Rodrigo E. Mendes, Anthony M. Nicasio et al. · Antimicrobial Agents and Chemotherapy · 2013 · 105 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection

Ólanrewaju O. Okusanya, Sujata M. Bhavnani, Jeffrey Hammel et al. · Antimicrobial Agents and Chemotherapy · 2009 · 101 citations

Medicine, Pharmacokinetics, Pharmacology +17

FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

Dianne Pulte, Kelly J. Norsworthy, Yaping Wang et al. · Clinical Cancer Research · 2021 · 81 citations · Full text

Medicine, Hematology, Pharmacology +14

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane

Brian VanScoy, Rodrigo E. Mendes, Jennifer McCauley et al. · Antimicrobial Agents and Chemotherapy · 2013 · 67 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model

Anthony M. Nicasio, Brian VanScoy, Rodrigo E. Mendes et al. · Antimicrobial Agents and Chemotherapy · 2016 · 58 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

1–5 of 21